Nebenwirkungen · Zebinix
Zebinix 400 mg tablets · Abschnitt 4.8 · PDF-Seite 27
HOS-120889 · Präparat HOS-095225
Table 1: Treatment emergent adverse reactions associated with Zebinix obtained clinical studies and post-marketing surveillance System Organ Very Common Uncommon Not known Class common Blood and Anaemia Thrombocytopenia, lymphatic leukopenia system disorders Immune system Hypersensitivity disorders Endocrine Hypothyroidism disorders Metabolism and Hyponatraemia, Electrolyte Inappropriate ADH nutrition decreased imbalance, secretion like disorders appetite dehydration, syndrome with hypochloraemia signs and symptoms of lethargy, nausea, dizziness, decrease in serum (blood) osmolality, vomiting, headache, confusional state or other neurological signs and symptoms
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-03-31T16:11:00Z · SHA-256 98408e074f33214cfe924a7f80a998379e63cc40b4a6143d82fe1b170ab3a743 · Passage f724835169634eedb7fb3d84c244c4f0afaba44b8379ca392422ac7488692500 · Zeichen 1780–3679 im Abschnitt